Blog

Demand for telehealth solutions has boomed over the past few years. Medicare telehealth visits alone grew from 840,000 in 2019 to 52.7 million in 2020, or 63-fold as shown right (source: Benesch Friedlander Coplan & Aronoff).

For cases deemed appropriate for telehealth, some studies have provided overwhelming evidence of increased patient satisfaction with remote visits compared to traditional in-person (urology; breast cancer; radiation oncology; general medicine). One of the main drivers? Convenience. Patients love removing the travel time and associated costs or tradeoffs that come with taking off work, finding childcare, and traveling to see a physician in person. Additionally, the CDC reports that 15%, or 49.8 million Americans live in rural parts of the U.S., which correlates with poorer health outcomes regardless of income level. Access to specialty carefor this population has been known to be especially difficult or impossible, but telehealth programs have introduced a new channel that many patients can take advantage of. 

In addition to increasing patient demand, there is a strong business case for Hospitals to expand their reach through telehealth modalities. A recent article by Purview's Dr. Christopher Schwartz, Remote Second Opinions: A Cure for the C-Suite Blues, describes the challenging financial state of many hospitals post-covid. Schwartz explains that, ‘during the lockdown alone, U.S. hospitalslost an estimated $22 billion in revenue due to cancellations in elective surgeries.’  Contrast this with the estimated value and market growth of the second opinion market at $10.7 billion by 2027with a CAGR 16.8%, and it is understandable why many hospitals are exploring the potential of these programs. Here, we outline key considerations for your organization as you assess readiness prior to launching a second opinion program.

Here’s a story we have heard too many times - You go to the doctor for a routine checkup, mammogram, or to have something looked at that seems abnormal. The doctor or radiologist decides to order a few more tests just to be safe, including a biopsy. After waiting anxiously for days or even weeks, the results arrive. It’s cancer. Finding out 'it's cancer' was the reality for nearly 2 million people across the United States in 2022 according to the CDC.

Many cancer patients and survivors describe everything after this as, ‘being in a fog,’ or ‘white noise,’ where it’s difficult or impossible to hear anything else being said after the words ‘you have cancer.’ Oncologists understand this and will usually suggest that a friend or family member also attend early appointments to take notes and provide emotional support.

Radiology reports are essential for documenting and sharing a physician's findings. There are many ways of formatting these reports. This blog explores the difference between two that are often confused as the same thing but are fundamentally different. Knowing the difference between these two types of reports is essential when talking to your cloud PACS vendor. 

As we near the end of 2022, we reflect on the past year of Purview's most read and shared blogs. Ranging from the new idea of establishing a 'virtual front door' in healthcare, to the impact of second opinions in pathology, patient resources, and the challenges that surround licensure in telehealth, these topics continue to resurface as we establish research and standards to inform what is best for today's patients in a rapidly changing field.